# Sato Pharmaceutical Co., Ltd. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/sato-pharmaceutical-co-ltd/5e274c7f-ada5-44d9-8c9b-068c7392b4ea

> Inspection records and compliance data for Sato Pharmaceutical Co., Ltd. in Hachioji, None. Access full analysis and detailed observations.

---

## Details

- Name: Sato Pharmaceutical Co., Ltd.
- FEI Number: 3004055563
- City: Hachioji
- State: None
- Country Name: Japan
- Address Line 1: 1468, Hazama-Machi
- Zip Code: None

## Related Documents

- [483 - Sato Pharmaceutical Co., Ltd. - 2025-11-21](https://www.globalkeysolutions.net/records/483/sato-pharmaceutical-co-ltd/451233fd-78de-4125-863c-922fc33c9f66) — source: FDA, date: November 21, 2025
- [483 - Sato Pharmaceutical Co., Ltd. - 2025-11-21](https://www.globalkeysolutions.net/records/483/sato-pharmaceutical-co-ltd/bb84423f-4e53-4ccc-bfc7-84c0590bba5f) — source: FDA, date: November 21, 2025
- [FDA Inspection 1292356 - Sato Pharmaceutical Co., Ltd. - 2025-11-21](https://www.globalkeysolutions.net/records/fda_inspections/sato-pharmaceutical-co-ltd/78dc6783-6b60-4d11-99c6-bd1e12334c10) — classification: Official Action Indicated (OAI), source: FDA, date: November 21, 2025
- [483 - Sato Pharmaceutical Co., Ltd. - 2025-11-13](https://www.globalkeysolutions.net/records/483/sato-pharmaceutical-co-ltd/b93ce6bc-4bf4-47a1-a948-0fb0ed61ef8c) — source: FDA, date: November 13, 2025
- [FDA Inspection 1111704 - Sato Pharmaceutical Co., Ltd. - 2019-11-07](https://www.globalkeysolutions.net/records/fda_inspections/sato-pharmaceutical-co-ltd/f303b0c8-052c-479f-a5eb-cee80b3d9998) — classification: No Action Indicated (NAI), source: FDA, date: November 7, 2019
- [FDA Inspection 1111704 - Sato Pharmaceutical Co., Ltd. - 2019-11-07](https://www.globalkeysolutions.net/records/fda_inspections/sato-pharmaceutical-co-ltd/4153faa6-6265-49c5-8afe-9a961309bc2f) — classification: No Action Indicated (NAI), source: FDA, date: November 7, 2019
- [483 - Sato Pharmaceutical Co., Ltd. - 2019-10-25](https://www.globalkeysolutions.net/records/483/sato-pharmaceutical-co-ltd/04496436-cb35-4c71-a66f-58ae024f0bc8) — source: FDA, date: October 25, 2019
- [FDA Inspection 1107699 - Sato Pharmaceutical Co., Ltd. - 2019-10-25](https://www.globalkeysolutions.net/records/fda_inspections/sato-pharmaceutical-co-ltd/eb00e326-37ea-4419-aaed-a041aad13d5a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 25, 2019
- [483 - Sato Pharmaceutical Co., Ltd. - 2018-07-03](https://www.globalkeysolutions.net/records/483/sato-pharmaceutical-co-ltd/bda58c1f-6dfc-4c9c-a3de-38805e3581c6) — source: FDA, date: July 3, 2018
- [483 - Sato Pharmaceutical Co., Ltd. - 2018-07-03](https://www.globalkeysolutions.net/records/483/sato-pharmaceutical-co-ltd/98b0da88-cb2a-4120-8872-f3fa327a7216) — source: FDA, date: July 3, 2018
- [FDA Inspection 1064716 - Sato Pharmaceutical Co., Ltd. - 2018-07-03](https://www.globalkeysolutions.net/records/fda_inspections/sato-pharmaceutical-co-ltd/9a4b8420-d982-428c-88b5-2785907b264c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 3, 2018
- [FDA Inspection 961508 - Sato Pharmaceutical Co., Ltd. - 2016-02-12](https://www.globalkeysolutions.net/records/fda_inspections/sato-pharmaceutical-co-ltd/7220a26f-ea4c-4152-b9aa-a7142357e82f) — classification: Official Action Indicated (OAI), source: FDA, date: February 12, 2016
- [FDA Inspection 808343 - Sato Pharmaceutical Co., Ltd. - 2012-11-16](https://www.globalkeysolutions.net/records/fda_inspections/sato-pharmaceutical-co-ltd/e6e13913-cf02-464a-a4d2-a5a891656660) — classification: No Action Indicated (NAI), source: FDA, date: November 16, 2012

## Related Companies

- [Clinical Resolution Laboratory Inc.](https://www.globalkeysolutions.net/companies/clinical-resolution-laboratory-inc/c7dca0ab-3aac-4500-9aa4-7ba4320b58cf)
- [Catalent Indiana, LLC](https://www.globalkeysolutions.net/companies/catalent-indiana-llc/3422c8c4-978a-45ba-962b-b00002fffd6d)
- [Creative Essences Inc](https://www.globalkeysolutions.net/companies/creative-essences-inc/ad4207ce-5720-4c6b-ad8b-7b67087bd0d9)
- [Daizo Corporation](https://www.globalkeysolutions.net/companies/daizo-corporation/7a66968e-4435-4dee-9c89-fa5c0a16db7a)
- [PRIME MATTER LABS WEST LLC](https://www.globalkeysolutions.net/companies/prime-matter-labs-west-llc/4df59898-79c3-47d4-afd9-8ee048c0d349)
- [Packpharm Limited](https://www.globalkeysolutions.net/companies/packpharm-limited/6289e413-3a35-4f76-9a93-6a7e5996c159)
- [Circadia by Dr Pugliese, Inc.](https://www.globalkeysolutions.net/companies/circadia-by-dr-pugliese-inc/57c47e31-5ddf-4413-85d3-b8925cbee6de)
- [Neva Global Grup Sanayi Ic Ve Dis Ticaret Anonim Sirketi](https://www.globalkeysolutions.net/companies/neva-global-grup-sanayi-ic-ve-dis-ticaret-anonim-sirketi/4c821d74-bd77-44b8-8756-e11ed1536058)
- [Premier Brands of America Inc.](https://www.globalkeysolutions.net/companies/premier-brands-of-america-inc/27ca3ffb-62da-4c8c-9a3a-468b417e7567)
- [Oy Finnsusp Ab](https://www.globalkeysolutions.net/companies/oy-finnsusp-ab/77b4381c-909d-4d9f-8f30-9ad92452b2d4)

## Related Officers

- [Steven M. Weinman](https://www.globalkeysolutions.net/people/steven-m-weinman/66ffc074-e34a-4b53-a525-0d4a25c6a220)
- [Gregory Stone](https://www.globalkeysolutions.net/people/gregory-stone/6fc15653-2d1b-46d6-89dd-655a40ea72de)
- [Jason R. Caballero](https://www.globalkeysolutions.net/people/jason-r-caballero/c2c8d281-0d02-459f-9541-bc04cb6d0a59)
- [Nibin Varghese](https://www.globalkeysolutions.net/people/nibin-varghese/43e17f63-2c1f-4d46-b26f-dc8ac8885438)
- [Consumer Safety Officer ](https://www.globalkeysolutions.net/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)